CHMP says yes to Novartis's Jakavi, BMS/AZ's Forxiga and Takeda's Rienso
This article was originally published in Scrip
Executive Summary
Three new drugs have this month won a green light from the European Medicine Agency's Committee for Medicinal Products for Human Use, while two others were again rebuffed.